Post by
templetooth2 on Nov 06, 2024 1:19pm
Mystery move: over $53
In the teeth of quite a significant ebitda miss for Q3 and reduced 2024 guidance!
My read: with Lina Khan gone, the possibility of a US buyer getting regulatory approval goes from less than 5% chance to probably in the range of 75% or more.
NCIB if acted on will retire about 1.9 million shares. Should cost about $105 million if done at an average $55 per share